Skip to content
Open access

Comprehensive Positive Airway Pressure Titration Parameters as Predictors of Therapeutic Adherence in Obstructive Sleep Apnea

Sep 2026 · Life · Vol 16 · 0 citations · 51 references
Medicine

TL;DR

Among the physiological parameters recorded during PAP titration, the lowest SpO2 was the most robust predictor of short-term adherence, independent of both baseline disease severity and baseline hypoxemia.

Abstract

Background: Whether the physiological response during positive airway pressure (PAP) titration predicts adherence independently of baseline severity is unclear. Methods: In 304 patients who underwent manual PAP titration at a tertiary university hospital between 2020 and 2022, adherence was defined by Korean reimbursement criteria (≥4 h/night on ≥70% of nights within any consecutive 30-day period during the initial 90 days). Titration parameters were compared using tests appropriate to each distribution and entered into logistic regression adjusted for age, sex, body mass index and baseline apnea–hypopnea index (AHI), with bootstrap validation. Results: Adherent (n = 238) and non-adherent (n = 66) groups had comparable baseline severity. Three titration parameters differed: AHI reduction rate (p = 0.033), lowest oxygen saturation (SpO2; p = 0.010) and rapid eye movement-sleep proportion (p = 0.021). Adding these parameters to a confounder-only model raised the area under the curve from 0.566 to 0.683 (p < 0.001; optimism-corrected, 0.632). Adjusted for confounders alone, all three were significant, but with mutual adjustment only the lowest SpO2 remained independent (odds ratio, 1.117 per 1%; 95% CI, 1.028–1.214). Conclusions: Among the physiological parameters recorded during PAP titration, the lowest SpO2 was the most robust predictor of short-term adherence, independent of both baseline disease severity and baseline hypoxemia. Prospective validation is required.

Read PDF

Similar papers

Open access Sep 2026

Can Sleep Hypoxic Measures Predict Long-Term Adherence to Positive Airway Pressure Treatments?

Obstructive sleep apnea (OSA) is a prevalent sleep-related breathing disorder characterized by recurrent upper airway collapse. Continuous positive airway pressure (CPAP) is the gold standard treatment but is burdened by low adherence rates. Nighttime hypoxia may alter sleep structure and OSA symptoms, potentially affe...

Andrea Portacci, S. Quaranta, C. Santomasi et al. · 0 citations
Open access Sep 2026

Sense of Coherence and Its Association With Adherence to Continuous Positive Airway Pressure (CPAP) Therapy in Patients With Obstructive Sleep Apnoea

It is suggested that low SOC is a risk factor for non-adherence to treatment and is a key clinical predictor for developing motivational strategies to improve treatment persistence in patients with OSA.

Monserrat Gómez Juárez, Fátima K. Gaytán Núñez, Francisco Vargas Hernández et al. · 0 citations
Open access Aug 2026

ASSOCIATION OF SPIROMETRIC PARAMETERS AND STOP BANG SCORE WITH SEVERITY OF OBSTRUCTIVE SLEEP APNEA: AN AMBISPECTIVE OBSERVATIONAL STUDY

Objective: Obstructive sleep apnea (OSA) is a common sleep-related breathing disorder associated with important cardiometabolic consequences. This study aimed to evaluate the relationship between spirometric parameters, STOP BANG score, and OSA severity in patients evaluated for suspected sleep-disordered breathing. Ma...

Tushar Gopalkrishna, Eldhos Jacob, Srishankar Bairy et al. · 0 citations
Open access Oct 2026

Conventional and novel hypoxemia-related indices for obstructive sleep apnea severity and incident hypertension: a prospective cohort study

Obstructive sleep apnea (OSA) is associated with hypertension (HTN), but the apnea–hypopnea index (AHI) and oxygen desaturation index (ODI) may not fully characterize nocturnal hypoxemia relevant to HTN development. We evaluated the associations of the sleep breathing impairment index (SBII) and hypoxic burden (HB)...

Li-Xia Wang, Xin-Jie Hui, Rong Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.